Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

Eur Urol. 2024 May 13:S0302-2838(24)02338-8. doi: 10.1016/j.eururo.2024.05.001. Online ahead of print.
No abstract available